GlobeNewswire Inc | Sep 11, 2020 08:00AM EDT

September 11, 2020

BASKING RIDGE, N.J., Sept. 11, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc.(Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that management is scheduled to present at the HC Wainwright Virtual 22nd Annual Global Investment Conference, which is being held from September 14-16, 2020.

Presentation details:

Date: Wednesday, September 16, 2020Time: 1:30-1:50pm EDT

A live webcast of the presentation will be available on the Investors section of the company's website:www.electrocore.com

About electroCore, Inc.

electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology. The companys current indications are the preventative treatment of cluster headache and migraine and acute treatment of migraine and episodic cluster headache.

For more information, visit:www.electrocore.com

Investors: Hans Vitzthum LifeSci Advisors 617-430-7578hans@lifesciadvisors.com

or

Media Contact: Jackie Dorsky electroCore 973-290-0097